Net profit of Biofil Chemicals & Pharmaceuticals rose 300.00% to Rs 0.08 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 461.83% to Rs 13.54 crore in the quarter ended September 2025 as against Rs 2.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales13.542.41 462 OPM %0.894.98 - PBDT0.180.13 38 PBT0.110.03 267 NP0.080.02 300 Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live News

Net profit of Biofil Chemicals & Pharmaceuticals rose 1317.65% to Rs 2.41 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. Sales declined 23.82% to Rs 6.43 crore in the quarter ended June 2025 as against Rs 8.44 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales6.438.44 -24 OPM %0.163.67 - PBDT2.830.33 758 PBT2.760.23 1100 NP2.410.17 1318 Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News